Shabber Mohammed

Title: Shabber Mohammed: Innovator in Prostaglandin Receptor Research

Introduction

Shabber Mohammed is a notable inventor based in Atlanta, GA (US). He has made significant contributions to the field of pharmacology, particularly in the development of compounds that target prostaglandin receptors.

Latest Patents

Shabber Mohammed holds a patent for "Prostaglandin receptor EP2 antagonists, derivatives, and uses related thereto." This patent discloses methods for treating or preventing various conditions and diseases where EP2 receptor activation plays a physiological role. These conditions include brain injury, inflammatory diseases, epilepsy, neuroinflammation after a seizure, pain, endometriosis, cancer, rheumatoid arthritis, skin inflammation, vascular inflammation, colitis, and neurological disorders. The patent emphasizes the administration of a pharmaceutical composition comprising the disclosed compounds to subjects in need.

Career Highlights

Shabber Mohammed is affiliated with Emory University, where he conducts research and develops innovative solutions in the medical field. His work has the potential to impact the treatment of several serious health conditions.

Collaborations

Shabber collaborates with esteemed colleagues such as Thota Ganesh and Raymond J Dingledine, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Shabber Mohammed's work in prostaglandin receptor research exemplifies the importance of innovation in addressing complex medical challenges. His contributions are paving the way for new therapeutic approaches that could significantly improve patient outcomes.